Works matching AU van Dongen, Guus A.M.S.

Results: 13

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.

Published in:

International Journal of Cancer, 1996, v. 68, n. 4, p. 520, doi. 10.1002/(SICI)1097-0215(19961115)68:4<520::AID-IJC19>3.0.CO;2-8

By:

Van Hal, Nicole L.W.;
Van Dongen, Guus A.M.S.;
Rood-Knippels, Ellen M.C.;
Van Der Valk, Paul;
Snow, Gordon B.;
Brakenhoff, Ruud H.

Publication type:

Article

Clonally Related But Phenotypically Divergent Human Cancer Cell Lines Derived from a Single Follicular Thyroid Cancer Recurrence (TT2609).

Published in:

Thyroid, 2001, v. 11, n. 10, p. 909, doi. 10.1089/105072501753210966

By:

Geldof, Albert A.;
Versteegh, Richard T.;
van Mourik, Johan C.;
Rooimans, Martin A.;
Arwert, Fre;
Hermsen, Mario A.J.A.;
Schadee-Eestermans, Inge L.;
van Dongen, Guus A.M.S.;
van der Valk, Paul;
van der Poest Clement, Evert H.;
Lips, Paul;
Teule, Gerrit J.J.

Publication type:

Article

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3545, doi. 10.1007/s00259-024-06785-9

By:

Muns, Joey A.;
Schooten, Erik;
van Dasselaar, Rychon D. J.;
Noordman, Yvet E.;
Adamzek, Kevin;
Eibergen, Arthur C.;
Pronk, Sebas D.;
Cali, Sagel;
Sijbrandi, Niels J.;
Merkul, Eugen;
Oliveira, Sabrina;
van Bergen en Henegouwen, Paul M.P.;
Takkenberg, R. Bart;
Verheij, Joanne;
van de Graaf, Stan F.J.;
Nijmeijer, Bart A.;
van Dongen, Guus A.M.S.

Publication type:

Article

89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2068, doi. 10.1007/s00259-023-06164-w

By:

Miedema, Iris H.C.;
Huisman, Marc C.;
Zwezerijnen, Gerben J.C.;
Grempler, Rolf;
Pitarch, Alejandro Perez;
Thiele, Andrea;
Hesse, Raphael;
Elgadi, Mabrouk;
Peltzer, Alexander;
Vugts, Danielle J.;
van Dongen, Guus A.M.S.;
de Gruijl, Tanja D.;
Menke-van der Houven van Oordt, C. Willemien;
Bahce, Idris

Publication type:

Article

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

Published in:

International Journal of Cancer, 2011, v. 129, n. 8, p. 2013, doi. 10.1002/ijc.26145

By:

Roovers, Rob C.;
Vosjan, Maria J.W.D.;
Laeremans, Toon;
el Khoulati, Rachid;
de Bruin, Renée C.G.;
Ferguson, Kathryn M.;
Verkleij, Arie J.;
van Dongen, Guus A.M.S.;
van Bergen en Henegouwen, Paul M.P.

Publication type:

Article

The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Published in:

Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665

By:

Aftimos, Philippe;
Rolfo, Christian;
Rottey, Sylvie;
Barthélémy, Philippe;
Borg, Christophe;
Park, Keunchil;
Oh, Do-Youn;
Kim, Sang-We;
De Jonge, Natalie;
Hanssens, Valérie;
Zwanenpoel, Karen;
Molthoff, Carla;
Vugts, Daniëlle;
Dreier, Torsten;
Verheesen, Peter;
van Dongen, Guus A.M.S.;
Jacobs, Julie;
Van Rompaey, Luc;
Hultberg, Anna;
Michieli, Paolo

Publication type:

Article

First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs).

Published in:

Expert Opinion on Drug Delivery, 2019, v. 16, n. 8, p. 783, doi. 10.1080/17425247.2019.1645118

By:

Merkul, Eugen;
Sijbrandi, Niels J.;
Muns, Joey A.;
Aydin, Ibrahim;
Adamzek, Kevin;
Houthoff, Hendrik-Jan;
Nijmeijer, Bart;
Van Dongen, Guus A.M.S.

Publication type:

Article

89Zr-rituximab PET/CT to detect neurolymphomatosis.

Published in:

American Journal of Hematology, 2016, v. 91, n. 6, p. 649, doi. 10.1002/ajh.24328

By:

de Jong, Antoinette;
Mous, Rogier;
van Dongen, Guus A.M.S.;
Hoekstra, Otto S.;
Nievelstein, Rutger A.J.;
de Keizer, Bart

Publication type:

Article

Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.

Published in:

International Journal of Cancer, 2003, v. 103, n. 6, p. 768, doi. 10.1002/ijc.10903

By:

de Nooij-van Dalen, Arnolda G.;
van Dongen, Guus A.M.S.;
Smeets, Serge J.;
Nieuwenhuis, Eline J.C.;
Stigter-van Walsum, Marijke;
Snow, Gordon B.;
Brakenhoff, Ruud H.

Publication type:

Article

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.

Published in:

International Journal of Cancer, 2002, v. 99, n. 3, p. 396, doi. 10.1002/ijc.10369

By:

Verel, Iris;
Heider, Karl-Heinz;
Siegmund, Miranda;
Ostermann, Elínborg;
Patzelt, Erik;
Sproll, Marlies;
Snow, Gordon B.;
Adolf, Günther R.;
van Dongen, Guus A.M.S.

Publication type:

Article

Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.

Published in:

International Journal of Cancer, 2002, v. 98, n. 5, p. 793, doi. 10.1002/ijc.10281

By:

Vrouenraets, Maarten B.;
Visser, Gerard W.M.;
Stigter, Marÿke;
Oppelaar, Hugo;
Snow, Gordon B.;
van Dongen, Guus A.M.S.

Publication type:

Article

Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.

Published in:

International Journal of Cancer, 2000, v. 88, n. 1, p. 108, doi. 10.1002/1097-0215(20001001)88:1<108::AID-IJC17>3.0.CO;2-H

By:

Vrouenraets, Maarten B.;
Visser, Gerard W.M.;
Loup, Christophe;
Meunier, Bernard;
Stigter, Marijke;
Oppelaar, Hugo;
Stewart, Fiona A.;
Snow, Gordon B.;
van Dongen, Guus A.M.S.

Publication type:

Article

Characterization of cd44v6 isoforms in head-and-neck squamous-cell carcinoma.

Published in:

International Journal of Cancer, 1999, v. 82, n. 6, p. 837, doi. 10.1002/(SICI)1097-0215(19990909)82:6<837::AID-IJC12>3.0.CO;2-H

By:

Van Hal, Nicole L.W.;
van Dongen, Guus A.M.S.;
Stigter-Van Walsum, Marijke;
Snow, Gordon B.;
Brakenhoff, Ruud H.

Publication type:

Article

Works matching AU van Dongen, Guus A.M.S.

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.

Clonally Related But Phenotypically Divergent Human Cancer Cell Lines Derived from a Single Follicular Thyroid Cancer Recurrence (TT2609).

Preclinical targeting of liver fibrosis with a <sup>89</sup>Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

<sup>89</sup>Zr-immuno-PET using the anti-LAG-3 tracer [<sup>89</sup>Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.

A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.

The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs).

<sup>89</sup>Zr-rituximab PET/CT to detect neurolymphomatosis.

Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.

Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.

Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.

Characterization of cd44v6 isoforms in head-and-neck squamous-cell carcinoma.